Follow us on:
Dedication / Services
To provide 50000 services and products to global scientific research units every year

elotuzumab

DESCRIPTION CATALOG # SIZE PRICE
Anti-SLAMF7 Therapeutic Antibody TAB-743 1mg Please Inquiry
Product Detail
Cat
TAB-743
Product Overview
Recombinant humanized antibody expressed in CHO binding to human SLAMF7/CD319. Elotuzumab is a humanized monoclonal antibody which is under phase III clinical investigation in relapsed multiple myeloma.
Target
SLAMF7/CD319
Type
IgG1 - kappa
Immunogen
The details of the immunogen for this antibody are not available.
Species Reactivity
Human
Expression Host
CHO
Applications
Suitable for use in FuncS, IF, Neut, ELISA, FC, IP, IHC and most other immunological methods.
CAS
915296-00-3
Predicted N terminal
EVQLVESG
Molecular Weight
145.5 kDa
Purity
>95.0%, determined by analysis by RP-HPLC & analysis by SDS-PAGE.
Size
1mg
Storage
Store at -20°C. Avoid multiple freeze/thaw cycles.
Background
Introduction
Elotuzumab (also known as HuLuc63) is a humanized monoclonal antibody which is under phase III clinical investigation in relapsed multiple myeloma.
Antigen Description
SLAM family member 7 is a protein that in humans is encoded by the SLAMF7 gene.
Function
receptor activity;
Gene ID
57823
Synonyms
SLAMF7; SLAM family member 7; 19A; CD319; CRACC; CS1; protein 19A; CD2 subset 1; 19A24 protein; membrane protein FOAP-12; CD2-like receptor activating cytotoxic cells; CD2-like receptor-activating cytotoxic cells; novel LY9 (lymphocyte antigen 9) like protein;
Download Datasheet:

Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us

Online Inquiry
Please input "biolabs"(case insensitive) as verification code.
Loading...
Contact Us

USA
Tel: 1-631-871-5806
Fax: 1-631-207-8356
Email: 

Europe
Tel: 44-207-097-1828


© 2007 - 2017 Creative-Biolabs All Rights Reserved